To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump
NCT06386952
Summary
Hypothesis: Double Hump in people with T2D is associated with higher magnitude of complication than people with single hump or no hump Objectives: To correlate single and double hump with diabetes complication T2DM patient will be recruited from endocrine OPD 1\. Clinical History and Examination: 1. General Physical Examination: Height, weight, waist circumference, hip circumference, BMI, Blood Pressure, Hand grip. Buffalo Hump. 2. Complications Assessment: Patient will be analyzed for: Micro Vascular (a) Diabetic retinopathy (i) Mild NPDR (ii) Mod NPDR (iii) Macular Edema / CSME (b) Neuropathy (Mild/Mod/Severe) (c) Chronic Kidney Disease (i) Micro/Macro albumin urea (ii) Increased Creatinine (iii) Decreased eGFR Macro Vascular 1. Low ABI/PAD 2. CVD-MI/PTCA/CABG/Heart Failure 3. CVS-Stroke/ TIA/Carotid Blockage \>50%
Eligibility
Inclusion Criteria: 1. Patients with T2DM (up to 30 years Duration) 2. Age 20 to 70 years 3. BMI \>25 kg/m² to \>40 kg/m² 4. Gender- Both (Male \& Female) Exclusion Criteria: 1. Alcoholic with Moderate to Severe. 2. BMI \>40 kg/m² 3. Congestive heart disease 4. Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg. consumption of amiodarone and tamoxifen) and congestive hepatopathy. 5. Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06386952